Cary, NC, United States of America

Deborah Barnette

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Deborah Barnette

Introduction

Deborah Barnette is a notable inventor based in Cary, NC (US). She has made significant contributions to the field of biotechnology, particularly in the development of compositions and methods that enhance the stability and efficacy of therapeutic proteins. With a total of two patents to her name, Barnette's work is recognized for its potential impact on medical treatments.

Latest Patents

Barnette's latest patents include a "Composition, method, and kit for alpha-1 proteinase inhibitor." This invention provides compositions that comprise alpha-1 proteinase inhibitor (API) and at least one amino acid. The liquid API formulation, which includes amino acids, is designed to afford stability to the API formulation. Another significant patent is for "Lyophilization methods, compositions, and kits." This patent outlines a method for lyophilization, particularly for formulations that include antithrombin III (AT III). It also details the compositions prepared from this method and the kits that comprise these compositions or lyophilized products.

Career Highlights

Deborah Barnette is currently associated with Grifols Therapeutics Inc., where she continues to innovate in the field of therapeutic proteins. Her work is characterized by a commitment to improving the stability and delivery of essential medical treatments.

Collaborations

Barnette collaborates with esteemed colleagues, including Jianxin Guo and Anthony Klos, who contribute to her research and development efforts.

Conclusion

Deborah Barnette's contributions to biotechnology through her patents and work at Grifols Therapeutics Inc. highlight her role as a significant innovator in the field. Her inventions have the potential to enhance therapeutic applications and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…